🚀💊 Are you ready to revolutionize the digital health and artificial intelligence (AI) sectors? Join the Merck Digital Sciences Studio (MDSS) and collaborate with a global leader! 🧬
🔍 The MDSS program in partnership with Centech Mtl and CQDM is a six-month program in Montreal that equips startups in the digital health and AI sectors with exclusive access to Merck’s experts, personalized mentoring from Centech’s Experts-in-Residence, and significant funding opportunities.
✨ Why choose the MDSS program in Montreal?
✔️ Mentoring: Receive tailored guidance from health sector experts to refine your business proposal and technology.
✔️ Workshops: Participate in specialized sessions with industry leaders to accelerate your startup’s growth.
✔️ Networking: Increase your exposure to key decision-makers and scientific leaders, paving the way for long-term collaborations.
✔️ Investment: Benefit from a $100,000 pre-seed investment from renowned health sector specialists, including CQDM.
🎯 Target Areas:
Digital Technologies for Preventive Health: AI solutions that span new ways to boost effectiveness in drug discovery & development to AI and digital technology platforms that provide anticipatory health risk.
Platforms for Biologics R&D: Develop platforms that enhance the research and development process for biologics, including proteins and antibodies, with improved data integration and workflow efficiency.
3D Translational Models: Utilize 3D biological models that closely replicate human tissues and organs to increase the precision of preclinical testing and shorten clinical trial timelines.
📅 Apply before April 4th to join the Merck Digital Sciences Studio! Accelerate the commercialization of your innovative solutions in digital health and AI! 👉 https://lnkd.in/gEuK8sQ8
Launch of Merck Digital Sciences Studio (MDSS) in Montréal
Related news
Our News
The 2025 RSRI Innovation Award is presented to Philippe Joubert, Yohan Bossé, and to Solutions de diagnostic BioMark
Our News
CQDM Funds Two Projects to Advance Preclinical Research Through the Use of Organoids
Our News